Price cap on stents, how hospitals and manufacturers may beat the cap

Hospitals and manufacturers are now faced with a reduction in profits margin of up to 85 percent following the price capping of cardiac stents. The price cap has had some unintended consequences. Amongst these are the myriad of ways both hospitals and manufacturers have tried to avoid the losses imposed on them by the cuts. …

Price cap on stents, how hospitals and manufacturers may beat the cap Read More »